Logo

Top 10 Articles on GenomeWeb in 2017: Supreme Court Ruling; FDA Guidelines for Precision Med; More

Dec 28, 2017 | staff reporter

NEW YORK (GenomeWeb) – What were the articles that gained the most interest from GenomeWeb readers this past year? The list is a cross-section of our coverage including a US Supreme Court decision, FDA guidelines, coverage of the JP Morgan Healthcare Conference, a notable acquisition, and a study of circulating tumor DNA for detecting early cancers, among others.

 Here are the top 10:

1)    Supreme Court Rules in Favor of Life Technologies in DNA Kit Component Case

2)    JPM Healthcare Day Two: 10x Genomics, Foundation Med, Quidel, Hologic, LabCorp, Nanostring, Bio-Rad

3)    FDA Releases Draft Guidelines to Clarify Regulatory Framework Supporting Precision Medicine

4)    Thermo Fisher Next-Gen Sequencing Panel Wins FDA Approval as Companion Test

5)    Illumina Launches NextSeq 550Dx, Expands Use of MiSeqDx

6)    Bio-Rad to Acquire RainDance Technologies

7)    Illumina Unveils New High-Throughput Sequencing Instrument at JP Morgan

8)    Counsyl Lays Off Oncology Sales Team

9)    FDA's Personalized Medicine Leader Leaving for Liquid Biopsy Startup Grail

10)  Sequencing of Circulating Tumor DNA Detects Early Cancers

Breaking News
The Scan

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.

Survey Sees Genetic Literacy on the Rise, Though Further Education Needed

Survey participants appear to have higher genetic familiarity, knowledge, and skills compared to 2013, though 'room for improvement' remains, an AJHG paper finds.

Study Reveals Molecular, Clinical Features in Colorectal Cancer Cases Involving Multiple Primary Tumors

Researchers compare mismatch repair, microsatellite instability, and tumor mutation burden patterns in synchronous multiple- or single primary colorectal cancers.

FarGen Phase One Sequences Exomes of Nearly 500 From Faroe Islands

The analysis in the European Journal of Human Genetics finds few rare variants and limited geographic structure among Faroese individuals.